Interpace Biosciences (IDXG) Profit Margin
Market Cap: $8.83M
Avg Volume: 7.93K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Profit Margin Summary (Annual)
According to Interpace Biosciences's latest annual financial reports, the company has an operating profit margin of 6.99%. This metric indicates the percentage of revenue that remains after deducting operating expenses, excluding interest and taxes.
The company's gross profit margin stands at 57.30%, reflecting the percentage of revenue that exceeds the cost of goods sold (COGS).
The pretax profit margin is 2.81%, indicating the percentage of revenue that remains after deducting all expenses except taxes.
Lastly, the net profit margin is 1.99%, which shows the percentage of revenue that remains as profit after all expenses, including taxes, have been deducted.
The trailing twelve months (TTM) operating profit margin is 10.64%, providing a more up-to-date view of the company's financial health.
Operating Margin
6.99%
Gross Margin
57.30%
Pretax Margin
2.81%
Net Margin
1.99%
Historical Operating Profit Margin
Historical Gross Profit Margin
Historical Pretax Profit Margin
Historical Net Profit Margin
Interpace Biosciences Historical Profit Margins
Interpace Biosciences Profit Margin History
The table below shows the margins for each year, with the latest data available for the last fiscal year 2023.
| Year | Operating Margin | Gross Margin | Pretax Margin | Net Margin |
|---|---|---|---|---|
| 2023 | 6.99% | 57.30% | 2.81% | 1.99% |
| 2022 | -12.06% | 57.26% | -18.33% | -18.42% |
| 2021 | -28.41% | 43.44% | -37.31% | -35.69% |
| 2020 | -81.96% | 33.10% | -80.71% | -80.87% |
| 2019 | -99.39% | 34.02% | -110.75% | -110.63% |
| 2018 | -55.35% | 53.43% | -55.66% | -55.67% |
| 2017 | -39.59% | 53.71% | -82.61% | -76.84% |
| 2016 | -49.23% | 49.25% | -65.51% | -63.68% |
| 2015 | -428.41% | 26.74% | -468.68% | -120.40% |
| 2014 | -11.23% | 15.46% | -11.79% | -13.40% |
| 2013 | -2.84% | 16.18% | -2.87% | -3.03% |
| 2012 | -19.88% | 21.17% | -19.91% | -20.12% |
| 2011 | -2.99% | 20.64% | -3.00% | -7.57% |
| 2010 | -2.98% | 22.26% | -2.88% | -4.71% |
| 2009 | -47.81% | 30.96% | -47.59% | -39.54% |
| 2008 | -32.37% | 4.01% | -29.85% | -30.62% |
| 2007 | -12.19% | 26.99% | -7.01% | -8.52% |
| 2006 | 2.47% | 23.34% | 4.45% | 4.94% |
| 2005 | -8.42% | 19.39% | -6.03% | -6.09% |
| 2004 | 9.66% | 27.12% | 9.87% | 5.80% |
| 2003 | 6.17% | 28.06% | 6.51% | 3.86% |
| 2002 | -17.67% | 10.52% | -16.97% | -10.83% |
| 2001 | 1.82% | 19.49% | 2.15% | 0.91% |
| 2000 | 9.81% | 27.49% | 10.97% | 6.48% |
| 1999 | 8.98% | 26.30% | 10.23% | 5.95% |
| 1998 | 9.10% | 23.15% | 11.08% | 9.40% |
| 1997 | 4.39% | 19.01% | -7.50% | -7.68% |